| D00085 |
Insulin (JAN/USP) |
(P) unclassified |
| D00186 |
Ciprofloxacin (JP18/USP/INN); Cipro (TN); Otiprio (TN) |
(P) unclassified |
| D00203 |
Amphotericin B (JP18/USP/INN); Ambisome (TN); Amphotec (TN); Fungizone (TN) |
(P) unclassified |
| D00211 |
Rifampin (USP); Rifampicin (JP18/INN); Rifadin (TN); Rimactane (TN) |
(P) CYP induction: CYP3A4 |
| D00216 |
Acarbose (JAN/USAN/INN); Precose (TN) |
(P) unclassified |
| D00219 |
Acetohexamide (JP18/USP/INN); Dymelor (TN) |
(P) unclassified |
| D00235 |
Atenolol (JP18/USP/INN); Tenormin (TN) |
(P) Enzyme: CYP2D6 |
| D00255 |
Carvedilol (JP18/USP/INN); Artist (TN); Coreg (TN) |
(P) Enzyme: CYP2D6 CYP3A4 |
| D00271 |
Chlorpropamide (JP18/USP/INN); Diabinese (TN) |
(P) unclassified |
| D00292 |
Dexamethasone (JP18/USP/INN); Decadron (TN); Maxidex (TN) |
(P) Enzyme: CYP3A4 / CYP induction: CYP3A4 |
| D00293 |
Diazepam (JP18/USP/INN); Diastat (TN); Valium (TN) |
(P) Enzyme: CYP3A4 |
| D00295 |
Cimetidine (JP18/USP/INN); Tagamet (TN) |
(P) CYP inhibition: CYP2D6 CYP3A4 |
| D00298 |
Digoxin (JP18/USP); Lanoxicaps (TN); Lanoxin (TN) |
(P) unclassified |
| D00335 |
Glipizide (USP/INN); Glucotrol (TN) |
(P) unclassified |
| D00336 |
Glyburide (USP); Glibenclamide (JP18/INN); Diabeta (TN); Glynase (TN); Micronase (TN) |
(P) Enzyme: CYP3A4 |
| D00378 |
Timolol (USAN); Timolol hemihydrate; Betimol (TN) |
(P) Enzyme: CYP2D6 |
| D00379 |
Tolazamide (JAN/USP/INN); Tolinase (TN) |
(P) unclassified |
| D00380 |
Tolbutamide (JAN/USP/INN); Orinase (TN) |
(P) unclassified |
| D00395 |
Troglitazone (JAN/USAN/INN); Rezulin (TN) |
(P) unclassified |
| D00420 |
Mitotane (JAN/USP/INN); Lysodren (TN) |
(P) unclassified |
| D00432 |
Nadolol (JP18/USP/INN); Corgard (TN) |
(P) unclassified |
| D00435 |
Nevirapine (JAN/USP/INN); Viramune (TN) |
(P) Enzyme: CYP3A4 CYP2D6 |
| D00483 |
Propranolol hydrochloride (JP18/USP); Inderal (TN); Innopran XL (TN) |
(P) Enzyme: CYP2D6 |
| D00506 |
Phenobarbital (JP18/USP/INN); Luminal (TN) |
(P) unclassified |
| D00512 |
Phenytoin (JP18/USP/INN); Dilantin (TN) |
(P) Target: SCN10A SCN11A SCN1A SCN2A SCN3A SCN4A SCN5A SCN8A SCN9A |
| D00513 |
Pindolol (JP18/USP/INN); Blocklin-L (TN); Carvisken (TN); Visken (TN) |
(P) Enzyme: CYP2D6 |
| D00550 |
Midazolam (JAN/USP/INN); Dormicum (TN); Buccolam (TN); Nayzilam (TN) |
(P) Enzyme: CYP3A4 |
| D00593 |
Glimepiride (JP18/USP/INN); Amaryl (TN) |
(P) unclassified |
| D00594 |
Repaglinide (JAN/USP/INN); Prandin (TN); Surepost (TN) |
(P) unclassified |
| D00595 |
Buformin (USAN/INN) |
(P) unclassified |
| D00596 |
Rosiglitazone maleate (JAN/USP); Avandia (TN) |
(P) unclassified |
| D00597 |
Acebutolol hydrochloride (JP18/USP); Sectral (TN) |
(P) unclassified |
| D00598 |
Betaxolol hydrochloride (JP18/USP); Betoptic (TN); Kerlone (TN) |
(P) unclassified |
| D00599 |
Carteolol hydrochloride (JP18/USP); Cartrol (TN); Ocupress (TN) |
(P) Enzyme: CYP2D6 |
| D00600 |
Labetalol hydrochloride (JP18/USP); Normodyne (TN); Trandate (TN) |
(P) unclassified |
| D00601 |
Metoprolol tartrate (JP18/USP); Lopressor (TN) |
(P) Enzyme: CYP2D6 |
| D00602 |
Penbutolol sulfate (JP18/USP); Levatol (TN) |
(P) unclassified |
| D00603 |
Timolol maleate (JP18/USP); Blocadren (TN); Istalol (TN); Timoptic (TN) |
(P) Enzyme: CYP2D6 |
| D00616 |
Diltiazem hydrochloride (JP18/USP); Cardizem (TN); Cartia XT (TN); Dilacor XR (TN); Dilt-CD (TN) |
(P) Enzyme: CYP3A4 |
| D00619 |
Verapamil hydrochloride (JP18/USP); Calan (TN); Covera-hs (TN); Vasolan (TN); Verelan (TN) |
(P) Enzyme: CYP3A4 / CYP inhibition: CYP3A4 |
| D00625 |
Miglitol (JP18/USAN/INN); Glyset (TN) |
(P) unclassified |
| D00634 |
Bisoprolol fumarate (JP18/USP); Zebeta (TN) |
(P) unclassified |
| D00635 |
Metoprolol succinate (USP); Toprol XL (TN) |
(P) Enzyme: CYP2D6 |
| D00636 |
Amiodarone hydrochloride (JP18/USP); Ancaron (TN); Cordarone (TN); Nexterone (TN) |
(CI,P) Enzyme: CYP3A4 / Target: SCN10A SCN11A SCN1A SCN2A SCN3A SCN4A SCN5A SCN8A SCN9A |
| D00644 |
Esmolol hydrochloride (JAN/USP); Brevibloc (TN) |
(P) unclassified |
| D00672 |
Hydroxyzine hydrochloride (JP18/USP); Hydroxyzine dihydrochloride; Atarax (TN); Vistaril (TN) |
(P) unclassified |
| D00701 |
Phenobarbital sodium (JAN/USP/INN); Luminal sodium (TN) |
(P) unclassified |
| D00738 |
Mepivacaine hydrochloride (JP18/USP); Carbocaine (TN); Polocaine (TN); Scandonest plain (TN) |
(P) Target: SCN10A SCN11A SCN1A SCN2A SCN3A SCN4A SCN5A SCN8A SCN9A |
| D00765 |
Rocuronium bromide (JAN/USP/INN); Zemuron (TN) |
(P) unclassified |
| D00776 |
Tizanidine hydrochloride (JP18/USP); Zanaflex (TN) |
(P) unclassified |
| D00809 |
Amitriptyline hydrochloride (JP18/USP); Elavil (TN) |
(P) Enzyme: CYP2D6 CYP3A4 |
| D00811 |
Clomipramine hydrochloride (JP18/USP); Anafranil (TN) |
(P) Enzyme: CYP2D6 CYP3A4 |
| D00815 |
Imipramine hydrochloride (JP18/USP); Tofranil (TN) |
(P) Enzyme: CYP2D6 CYP3A4 |
| D00818 |
Maprotiline hydrochloride (JP18/USP); Ludiomil (TN) |
(P) Enzyme: CYP2D6 |
| D00831 |
Mefloquine hydrochloride (JP18/USP); Lariam (TN) |
(P) unclassified |
| D00874 |
Moxifloxacin hydrochloride (JAN/USP); Avelox (TN); Vigamox (TN) |
(CI) unclassified |
| D00944 |
Metformin hydrochloride (JP18/USP); Glucophage (TN) |
(P) unclassified |
| D00945 |
Pioglitazone hydrochloride (JP18/USP); Actos (TN) |
(P) unclassified |
| D00961 |
Bicalutamide (JP18/USP/INN); Casodex (TN) |
(P) CYP inhibition: CYP3A4 |
| D00967 |
Toremifene citrate (JAN/USAN); Fareston (TN) |
(CI) Enzyme: CYP3A4 |
| D01025 |
Levobunolol hydrochloride (JAN/USP); Betagan (TN) |
(P) unclassified |
| D01026 |
Sotalol hydrochloride (JAN/USP); Betapace (TN); Sorine (TN) |
(P) unclassified |
| D01096 |
Hydroxyzine pamoate (JP18/USP); Atarax-P (TN); Vistaril pamoate (TN) |
(P) unclassified |
| D01111 |
Nateglinide (JP18/USP/INN); Starsis (TN) |
(P) unclassified |
| D01179 |
Duloxetine hydrochloride (JAN/USP); Cymbalta (TN); Yentreve (TN) |
(P) CYP inhibition: CYP2D6 |
| D01182 |
Alprenolol hydrochloride (JP18/USAN); Regletin (TN) |
(P) Enzyme: CYP2D6 |
| D01240 |
Deslanoside (JP18/USP/INN); Cedilanid-d (TN) |
(P) unclassified |
| D01253 |
Clobazam (JAN/USAN/INN); Mystan (TN); Onfi (TN) |
(P) Enzyme: CYP3A4 |
| D01280 |
Warfarin potassium (JP18); Athrombin-K (TN) |
(P) unclassified |
| D01356 |
Glymidine sodium (JAN/USAN/INN) |
(P) unclassified |
| D01369 |
Bevantolol hydrochloride (JAN/USAN); Calvan (TN); Vantol (TN) |
(P) unclassified |
| D01454 |
Bupranolol hydrochloride (JP18) |
(P) unclassified |
| D01469 |
Amosulalol hydrochloride (JP18); Lowgan (TN) |
(P) unclassified |
| D01471 |
Esatenolol (JAN/INN); (S)-Atenolol |
(P) unclassified |
| D01492 |
Bucumolol hydrochloride (JP18) |
(P) unclassified |
| D01504 |
Bufetolol hydrochloride (JP18); Adobiol (TN) |
(P) unclassified |
| D01512 |
Befunolol hydrochloride (JAN); Bentos (TN) |
(P) unclassified |
| D01599 |
Gliclazide (JP18/INN); Glimicron (TN) |
(P) unclassified |
| D01665 |
Voglibose (JP18/USAN/INN); Basen (TN) |
(P) unclassified |
| D01691 |
Nipradilol (JAN/INN); Hypadil (TN) |
(P) unclassified |
| D01710 |
Roxithromycin (JP18/USAN/INN); Rulide (TN) |
(P) unclassified |
| D01741 |
Celiprolol hydrochloride (JAN/USAN); Selectol (TN) |
(P) unclassified |
| D01794 |
Bopindolol malonate (JAN); Sandonorm (TN) |
(P) Enzyme: CYP2D6 |
| D01795 |
Tilisolol hydrochloride (JAN); Selecal (TN) |
(P) unclassified |
| D01799 |
Glyclopyramide (JAN/INN); Deamelin-S (TN) |
(P) unclassified |
| D01806 |
Oxprenolol hydrochloride (JP18/USP); Okuspurecol (TN) |
(P) unclassified |
| D01830 |
Arotinolol hydrochloride (JP18); Almarl (TN) |
(P) unclassified |
| D01847 |
Landiolol hydrochloride (JAN/USAN); ONO 1101 hydrochloride; Onoact (TN); Rapiblyk (TN) |
(P) unclassified |
| D01854 |
Mitiglinide calcium hydrate (JP18); Mitiglinide calcium dihydrate; Glufast (TN) |
(P) unclassified |
| D01856 |
Nifekalant hydrochloride (JAN); MS 551; Shinbit (TN) |
(P) unclassified |
| D01958 |
Indenolol hydrochloride (JP18) |
(P) unclassified |
| D02081 |
Metipranolol hydrochloride; Optipranolol (TN) |
(P) unclassified |
| D02102 |
Methadone hydrochloride (JAN/USP); Dolophine hydrochloride (TN) |
(P) Enzyme: CYP2D6 CYP3A4 / CYP induction: CYP3A4 |
| D02103 |
Phenytoin sodium (USP); Phenytoin sodium for injection (JP18); Aleviatin (TN); Dilantin (TN) |
(P) Target: SCN10A SCN11A SCN1A SCN2A SCN3A SCN4A SCN5A SCN8A SCN9A |
| D02106 |
Arsenic trioxide (JP18/USAN); Trisenox (TN) |
(P) unclassified |
| D02126 |
Primaquine phosphate (JAN/USP); Primaquine (TN) |
(P) unclassified |
| D02206 |
Buformin hydrochloride (JP18); Dibetos-B (TN) |
(P) unclassified |
| D02216 |
Ciprofloxacin hydrochloride (USP); Ciprofloxacin hydrochloride hydrate (JP18); Ciloxan (TN); Cipro (TN); Proquin XR (TN) |
(P) unclassified |
| D02260 |
Paroxetine hydrochloride hemihydrate (USP); Paroxetine hydrochloride hydrate (JP18); Paxil (TN) |
(P) Enzyme: CYP2D6 / CYP inhibition: CYP2D6 |
| D02323 |
Tolrestat (USAN/INN); Alredase (TN) |
(P) unclassified |
| D02338 |
Acebutolol (USAN/INN) |
(P) unclassified |
| D02342 |
Bisoprolol (JAN/USAN/INN) |
(P) unclassified |
| D02358 |
Metoprolol (USAN/INN) |
(P) Enzyme: CYP2D6 |
| D02372 |
Perospirone hydrochloride hydrate (JAN); Lullan (TN) |
(P) unclassified |
| D02374 |
Metipranolol (USAN/INN) |
(P) unclassified |
| D02389 |
Primidolol (USAN/INN) |
(P) unclassified |
| D02425 |
Carbutamide (INN); Invenol (TN) |
(P) unclassified |
| D02426 |
Glycyclamide (INN); Tolcyclamide |
(P) unclassified |
| D02427 |
Glibornuride (USAN/INN); Glutril (TN) |
(P) unclassified |
| D02428 |
Glisentide (INN); Glypentide; Staticum (TN) |
(P) unclassified |
| D02429 |
Glisolamide (INN); Glysolamide; Diabenor (TN) |
(P) unclassified |
| D02430 |
Gliquidone (INN); Glurenorm (TN) |
(P) unclassified |
| D02484 |
Artemether and lumefantrine; Coartem (TN) |
(P) unclassified |
| D02540 |
Garenoxacin mesylate (USAN); Garenoxacin mesilate hydrate (JAN) |
(P) unclassified |
| D02567 |
Escitalopram oxalate (JAN/USP); Lexapro (TN) |
(P) Enzyme: CYP2D6 CYP3A4 / CYP inhibition: CYP2D6 |
| D02587 |
Metildigoxin (JP18); Lanirapid (TN) |
(P) unclassified |
| D02691 |
Somatropin (USP/INN); Somatropin (genetical recombination) (JAN); Human growth hormone (JAN); Asellacrin (TN); Humatrope (TN); Nutropin (TN); Omnitrope (TN) |
(P) unclassified |
| D02732 |
Pranlukast hydrate (JP18); Onon (TN) |
(P) Enzyme: CYP3A4 |
| D02740 |
Lidocaine and prilocaine; Lidocaine and propitocaine; Emla (TN); Oraqix (TN); Lidocaine and prilocaine (TN) |
(P) Enzyme: CYP3A4 |
| D02765 |
Adaprolol maleate (USAN) |
(P) unclassified |
| D02834 |
Alprenoxime hydrochloride (USAN) |
(P) unclassified |
| D02968 |
Aprepitant (JAN/USP/INN); Aponvie (TN); Emend (TN); Cinvanti (TN) |
(P) Enzyme: CYP3A4 / CYP inhibition: CYP3A4 / CYP induction: CYP3A4 |
| D03106 |
Bexarotene (JAN/USAN/INN); Targretin (TN) |
(P) unclassified |
| D03170 |
Bucindolol hydrochloride (USAN) |
(P) unclassified |
| D03177 |
Bunolol hydrochloride (USAN) |
(P) unclassified |
| D03198 |
Butoxamine hydrochloride (USAN) |
(P) unclassified |
| D03230 |
Insulin human (USP/INN); Insulin human (genetical recombination) (JP18); Insulin human (biosynthesis) (JAN); Insulin human (synthesis) (JAN); Humulin (TN) |
(P) unclassified |
| D03250 |
Insulin glargine (USAN/INN); Insulin glargine (genetical recombination) (JP18); Insulin glargine (genetical recombination) [Insulin glargin biosimilar 1] (JAN); Insulin glargine (genetical recombination) [Insulin glargin biosimilar 2] (JAN); Insulin glargine-yfgn; Lantus (TN) |
(P) unclassified |
| D03260 |
Vardenafil hydrochloride hydrate (JAN); Vardenafil monohydrochloride trihydrate; Levitra (TN); Staxyn (TN) |
(CI) Enzyme: CYP3A4 |
| D03342 |
Camiglibose (USAN) |
(P) unclassified |
| D03449 |
Cetamolol hydrochloride (USAN) |
(P) unclassified |
| D03490 |
Cicloprolol hydrochloride (USAN) |
(P) unclassified |
| D03493 |
Ciglitazone (USAN/INN) |
(P) unclassified |
| D03653 |
Darglitazone sodium (USAN) |
(P) unclassified |
| D03658 |
Dasatinib (JAN/INN) |
(P) Enzyme: CYP3A4 |
| D03669 |
Deferasirox (JAN/USAN/INN); Exjade (TN); Jadenu (TN) |
(P) CYP induction: CYP3A4 |
| D03729 |
Dexpropranolol hydrochloride (USAN) |
(P) unclassified |
| D03759 |
Diacetolol hydrochloride (USAN) |
(P) unclassified |
| D03941 |
Edaglitazone sodium (USAN) |
(P) unclassified |
| D03996 |
Englitazone sodium (USAN) |
(P) unclassified |
| D04024 |
Lapatinib ditosylate (USAN); Lapatinib tosilate hydrate (JAN); Lapatinib ditosylate monohydrate; Tykerb (TN); Tyverb (TN) |
(P) Enzyme: CYP3A4 |
| D04103 |
Etoformin hydrochloride (USAN) |
(P) unclassified |
| D04121 |
Exenatide (JAN/USAN/INN); Byetta (TN) |
(P) unclassified |
| D04187 |
Fingolimod hydrochloride (JAN/USAN); Gilenya (TN) |
(CI) unclassified |
| D04190 |
Flestolol sulfate (USAN) |
(P) unclassified |
| D04322 |
Gliamilide (USAN/INN) |
(P) unclassified |
| D04354 |
Glyhexamide (USAN/INN); Subose (TN) |
(P) unclassified |
| D04355 |
Glyoctamide (USAN/INN) |
(P) unclassified |
| D04356 |
Glyparamide (USAN) |
(P) unclassified |
| D04403 |
Guar gum (NF) |
(P) unclassified |
| D04475 |
Insulin aspart (USP/INN); Insulin aspart (genetical recombination) (JP18); Insulin aspart (genetical recombination) [Insulin aspart biosimilar 1] (JAN); Insulin X 14; Insulin aspart-szjj; Merilog (TN); NovoRapid (TN); Novolog (TN) |
(P) unclassified |
| D04477 |
Insulin lispro (USP/INN); Insulin lispro (genetical recombination) (JAN); Insulin lispro (genetical recombination) [Insulin lispro Biosimilar 1] (JAN); Insulin lispro-aabc; Humalog (TN); Lyumjev (TN) |
(P) unclassified |
| D04539 |
Insulin detemir (USAN/INN); Insulin detemir (genetical recombination) (JAN); Levemir (TN) |
(P) unclassified |
| D04540 |
Insulin glulisine (USAN/INN); Insulin glulisine (genetical recombination) (JAN); Apidra (TN) |
(P) unclassified |
| D04541 |
Insulin human, isophane (USP) |
(P) unclassified |
| D04542 |
Insulin human zinc (USP) |
(P) unclassified |
| D04543 |
Insulin human zinc, extended (USP) |
(P) unclassified |
| D04547 |
Insulin, isophane (USP); Isophane insulin human (genetical recombination) injectable aqueous suspension (JP18); Isophane insulin (aqueous suspension) (JAN); Humalog PEN (TN) |
(P) unclassified |
| D04548 |
Insulin, neutral (USAN); Neutral insulin injection (INN) |
(P) unclassified |
| D04550 |
Insulin zinc, prompt (USP); Semilente iletin (TN) |
(P) unclassified |
| D04551 |
Insulin zinc (USP); Lente iletin (TN) |
(P) unclassified |
| D04641 |
Istradefylline (JAN/USAN/INN); Nourianz (TN); Nouriast (TN) |
(P) Enzyme: CYP3A4 / CYP inhibition: CYP3A4 |
| D04666 |
Lanreotide acetate (JAN/USAN); Somatuline (TN) |
(P) unclassified |
| D04710 |
Levobetaxolol hydrochloride (USAN); Betaxon (TN) |
(P) unclassified |
| D04888 |
Medroxalol (USAN/INN) |
(P) unclassified |
| D04889 |
Medroxalol hydrochloride (USAN) |
(P) unclassified |
| D04966 |
Metformin (USAN/INN) |
(P) unclassified |
| D05011 |
Metoprolol fumarate (USP); Lopressor (TN) |
(P) Enzyme: CYP2D6 |
| D05127 |
Nebivolol (USAN/INN) |
(P) Enzyme: CYP2D6 |
| D05150 |
Netoglitazone (USAN/INN) |
(P) unclassified |
| D05277 |
Formoterol fumarate hydrate (JP18); Formoterol fumarate dihydrate; Atock (TN); Foradil (TN) |
(P) unclassified |
| D05345 |
Pamatolol sulfate (USAN) |
(P) unclassified |
| D05380 |
Pazopanib hydrochloride (JAN/USAN); Votrient (TN) |
(P) unclassified |
| D05587 |
Practolol (USAN) |
(P) unclassified |
| D05594 |
Pramlintide (USAN/INN) |
(P) unclassified |
| D05595 |
Pramlintide acetate (USAN); Symlin (TN) |
(P) unclassified |
| D05622 |
Proinsulin human (USAN) |
(P) unclassified |
| D05739 |
Rivoglitazone (USAN/INN) |
(P) unclassified |
| D05775 |
Rufinamide (JAN/USP/INN); Banzel (TN) |
(P) Target: SCN10A SCN11A SCN1A SCN2A SCN3A SCN4A SCN5A SCN8A SCN9A |
| D05908 |
Spiramycin (JAN/USAN/INN); Rovamycin (TN) |
(P) unclassified |
| D06177 |
Tolbutamide sodium, sterile; Orinase diagnostic (TN) |
(P) unclassified |
| D06186 |
Tolpyrramide (USAN/INN) |
(P) unclassified |
| D06402 |
Sunitinib malate (JAN/USAN); Sutent (TN) |
(P) Enzyme: CYP3A4 |
| D06404 |
Liraglutide (USAN/INN); Liraglutide (genetical recombination) (JAN); Victoza (TN) |
(P) unclassified |
| D06407 |
Vandetanib (JAN/USAN/INN); Caprelsa (TN) |
(P) Enzyme: CYP3A4 |
| D06413 |
Nilotinib hydrochloride hydrate (JAN); Nilotinib monohydrochloride monohydrate; Tasigna (TN) |
(P) Enzyme: CYP3A4 |
| D06414 |
Dasatinib (USAN); Dasatinib hydrate (JAN); Sprycel (TN) |
(P) Enzyme: CYP3A4 |
| D06553 |
Alogliptin benzoate (JAN/USAN); Vipidia (TN); Nesina (TN) |
(P) unclassified |
| D06578 |
Denagliptin tosylate (USAN) |
(P) unclassified |
| D06597 |
Fosaprepitant dimeglumine (USAN); Fosaprepitant meglumine (JAN); Proemend (TN) |
(P) Enzyme: CYP3A4 / CYP inhibition: CYP3A4 / CYP induction: CYP3A4 |
| D06622 |
Nebivolol hydrochloride (USAN); Bystolic (TN) |
(P) Enzyme: CYP2D6 |
| D06637 |
Romidepsin (JAN/USAN/INN); Istodax (TN) |
(P) unclassified |
| D06641 |
Sergliflozin etabonate (USAN) |
(P) unclassified |
| D06645 |
Sitagliptin phosphate (USAN); Sitagliptin phosphate hydrate (JP18); Sitagliptin phosphate monohydrate; Januvia (TN) |
(P) unclassified |
| D06646 |
Epanolol (USAN/INN) |
(P) unclassified |
| D07080 |
Vildagliptin (JAN/USAN/INN); Equa (TN); Galvus (TN) |
(P) unclassified |
| D07117 |
Metahexamide (INN) |
(P) unclassified |
| D07118 |
Glisoxepide (INN) |
(P) unclassified |
| D07156 |
Alprenolol (INN) |
(P) Enzyme: CYP2D6 |
| D07181 |
Mepindolol (INN) |
(P) unclassified |
| D07182 |
Tertatolol (INN) |
(P) unclassified |
| D07183 |
Cloranolol (INN) |
(P) unclassified |
| D07184 |
Talinolol (INN) |
(P) unclassified |
| D07192 |
Benfluorex (INN/BAN); Mediaxal (TN) |
(P) unclassified |
| D07496 |
Befunolol (INN) |
(P) unclassified |
| D07508 |
Benfluorex hydrochloride; Mediator (TN) |
(P) unclassified |
| D07526 |
Betaxolol (INN); Betaxolol (TN) |
(P) unclassified |
| D07537 |
Bopindolol (INN); Sandonorm (TN) |
(P) Enzyme: CYP2D6 |
| D07583 |
Phenytoin and phenobarbital; Aleviatin with phenobarbital (TN) |
(P) unclassified |
| D07590 |
Bupranolol (INN) |
(P) unclassified |
| D07595 |
Fosphenytoin sodium hydrate (JAN); Fostoin (TN) |
(P) Target: SCN10A SCN11A SCN1A SCN2A SCN3A SCN4A SCN5A SCN8A SCN9A / CYP induction: CYP3A4 |
| D07608 |
Carazolol (INN); Conducton (TN); Suacron [veterinary] (TN) |
(P) unclassified |
| D07624 |
Carteolol (INN) |
(P) Enzyme: CYP2D6 |
| D07660 |
Celiprolol (INN); Celiprolol PCH (TN) |
(P) unclassified |
| D07916 |
Esmolol (INN) |
(P) unclassified |
| D08074 |
Penbutolol (INN) |
(P) unclassified |
| D08078 |
Indenolol (INN) |
(P) unclassified |
| D08080 |
Insulin injection, biphasic isophane (BAN); Biphasic isophane insuline human (genetical recombination) injectable aqueous suspension (JP18); Insulin Humacart (TN) |
(P) unclassified |
| D08115 |
Levobunolol (INN) |
(P) unclassified |
| D08318 |
Oxprenolol (INN); Oxprenolol (TN) |
(P) unclassified |
| D08351 |
Phenformin (BAN) |
(P) Enzyme: CYP2D6 |
| D08352 |
Phenformin hydrochloride; Debei (TN) |
(P) Enzyme: CYP2D6 |
| D08378 |
Pioglitazone (INN); Actos (TN) |
(P) unclassified |
| D08443 |
Propranolol (INN); Propranolol (TN) |
(P) Enzyme: CYP2D6 |
| D08491 |
Rosiglitazone (INN); Gaudil (TN) |
(P) unclassified |
| D08516 |
Sitagliptin (USAN/INN) |
(P) unclassified |
| D08525 |
Sotalol (INN); Darob mite (TN) |
(P) unclassified |
| D08572 |
Tertatolol hydrochloride; Artex (TN) |
(P) unclassified |
| D08598 |
Tilisolol (INN) |
(P) unclassified |
| D08600 |
Timolol (INN); Timolol (TN); Betimol (TN) |
(P) Enzyme: CYP2D6 |
| D08616 |
Teneligliptin (INN) |
(P) Enzyme: CYP3A4 / CYP inhibition: CYP2D6 CYP3A4 |
| D08631 |
Carmegliptin (USAN/INN) |
(P) unclassified |
| D08843 |
Albiglutide (USAN); Albiglutide (genetical recombination) (JAN); Tanzeum (TN) |
(P) unclassified |
| D08856 |
Anamorelin hydrochloride (JAN/USAN); Adlumiz (TN) |
(P) Enzyme: CYP3A4 |
| D08897 |
Dapagliflozin (JAN/USAN/INN); Forxiga (TN) |
(P) unclassified |
| D08996 |
Saxagliptin (USAN/INN) |
(P) Enzyme: CYP3A4 |
| D09013 |
Teplizumab (USAN/INN); Teplizumab-mzwv; Tzield (TN) |
(P) unclassified |
| D09326 |
Carmegliptin dihydrochloride (USAN) |
(P) unclassified |
| D09333 |
Dutogliptin (USAN) |
(P) unclassified |
| D09334 |
Dutogliptin tartrate (USAN) |
(P) unclassified |
| D09535 |
Mirabegron (JAN/USAN/INN); Myrbetriq (TN) |
(P) Enzyme: CYP3A4 / CYP inhibition: CYP2D6 |
| D09566 |
Linagliptin (JAN/USAN/INN); Tradjenta (TN) |
(P) unclassified |
| D09592 |
Canagliflozin (USAN/INN); Canagliflozin hydrate (JAN); Invokana (TN) |
(P) unclassified |
| D09595 |
Budesonide and formoterol fumarate dihydrate; Symbicort (TN); Budeforu (TN) |
(P) Enzyme: CYP3A4 |
| D09605 |
Duvoglustat (USAN/INN); 1-Deoxynojirimycin |
(P) unclassified |
| D09606 |
Duvoglustat hydrochloride (USAN) |
(P) unclassified |
| D09625 |
Gosogliptin (USAN/INN) |
(P) unclassified |
| D09638 |
Lomitapide mesylate (USAN); Lomitapide mesilate (JAN); Juxtapid (TN); Lojuxta (TN) |
(P) Enzyme: CYP3A4 |
| D09701 |
Abiraterone acetate (JAN/USP); Zytiga (TN) |
(P) Enzyme: CYP3A4 |
| D09723 |
Taspoglutide (USAN/INN) |
(P) unclassified |
| D09727 |
Insulin degludec (USAN/INN); Insulin degludec (genetical recombination) (JAN); Tresiba (TN) |
(P) unclassified |
| D09729 |
Lixisenatide (JAN/USAN/INN); Adlyxin (TN); Lyxumia (TN) |
(P) unclassified |
| D09731 |
Crizotinib (JAN/USAN/INN); Xalkori (TN) |
(P) Enzyme: CYP3A4 |
| D09744 |
Pioglitazone hydrochloride and metformin hydrochloride (JP18); Pioglitazone and metformin; Metact (TN) |
(P) unclassified |
| D09753 |
Saxagliptin hydrate (JAN); Onglyza (TN) |
(P) Enzyme: CYP3A4 |
| D09756 |
Teneligliptin hydrobromide hydrate (JAN) |
(P) Enzyme: CYP3A4 / CYP inhibition: CYP2D6 CYP3A4 |
| D09763 |
Dapagliflozin propanediol (USAN); Dapagliflozin propylene glycolate hydrate (JAN); Dapagliflozin propandiol monohydrate; Forxiga (TN); Farxiga (TN) |
(P) unclassified |
| D09779 |
Emiglitate (JAN/INN) |
(P) unclassified |
| D09780 |
Anagliptin (JAN/INN) |
(P) unclassified |
| D09785 |
Delamanid (JAN/USAN); Deltyba (TN) |
(P) Enzyme: CYP2D6 CYP3A4 |
| D09799 |
Carotegrast methyl (JAN); Carogra (TN) |
(P) CYP inhibition: CYP3A4 |
| D09843 |
Beradilol monoethyl maleate (JAN); TZC-5665 |
(P) unclassified |
| D09848 |
Pioglitazone hydrochloride and glimepiride tablets (JP18); Pioglitazone and glimepiride; Duetact; Sonias (TN) |
(P) unclassified |
| D09889 |
Dulaglutide (USAN/INN); Dulaglutide (genetical recombination) (JAN); Trulicity (TN) |
(P) unclassified |
| D09894 |
Eliglustat tartrate (JAN/USAN); Eliglustat hemitartrate; Cerdelga (TN) |
(CI,P) Enzyme: CYP2D6 |
| D09978 |
Tofogliflozin (USAN); Tofogliflozin hydrate (JAN); Apleway (TN); Deberza (TN) |
(P) unclassified |
| D09996 |
Vemurafenib (JAN/USAN/INN); Zelboraf (TN) |
(P) CYP induction: CYP3A4 |
| D10003 |
Hemin (JAN); Normosang (TN); Panhematin (TN) |
(P) CYP induction: CYP3A4 CYP2D6 |
| D10025 |
Semaglutide (USAN/INN); Semaglutide (genetical recombination) (JAN); Ozempic (TN) |
(P) unclassified |
| D10055 |
Remogliflozin etabonate (USAN/INN) |
(P) unclassified |
| D10104 |
Dabrafenib mesylate (USAN); Dabrafenib mesilate (JAN); Tafinlar (TN) |
(P) Enzyme: CYP3A4 / CYP induction: CYP3A4 |
| D10159 |
Alogliptin benzoate and pioglitazone hydrochloride; Liovel (TN); Oseni (TN); Incresync (TN) |
(P) unclassified |
| D10160 |
Mitiglinide calcium hydrate and voglibose; Glubes (TN) |
(P) unclassified |
| D10161 |
Sarilumab (USAN); Sarilumab (genetical receombination) (JAN); Kevzara (TN) |
(P) unclassified |
| D10178 |
Trelagliptin (USAN) |
(P) Enzyme: CYP2D6 |
| D10179 |
Trelagliptin succinate (JAN/USAN); Zafatek (TN) |
(P) Enzyme: CYP2D6 |
| D10195 |
Luseogliflozin hydrate (JAN); Lusefi (TN) |
(P) unclassified |
| D10196 |
Ipragliflozin (INN) |
(P) unclassified |
| D10200 |
Ipragliflozin L-proline (JAN); Suglat (TN) |
(P) unclassified |
| D10218 |
Enzalutamide (JAN/USAN); Xtandi (TN) |
(P) unclassified |
| D10244 |
Metformin hydrochloride and rosiglitazone maleate; Avandamet (TN) |
(P) unclassified |
| D10251 |
Glimepiride and rosiglitazone maleate; Avandaryl (TN) |
(P) unclassified |
| D10253 |
Alogliptin benzoate and metformin hydrochloride; Kazano (TN); Vipdomet (TN) |
(P) unclassified |
| D10255 |
Anagrelide hydrochloride hydrate (JAN); Anagrelide hydrochloride monohydrate; Agrylin (TN) |
(P) unclassified |
| D10258 |
Simvastatin and sitagliptin phosphate; Juvisync (TN) |
(P) unclassified |
| D10261 |
Metformin hydrochloride and sitagliptin phosphate; Janumet (TN) |
(P) unclassified |
| D10262 |
Saxagliptin hydrochloride; Onglyza (TN) |
(P) Enzyme: CYP3A4 |
| D10263 |
Metformin hydrochloride and saxagliptin hydrochloride; Kombiglyze (TN) |
(P) Enzyme: CYP3A4 |
| D10264 |
Linagliptin and metformin hydrochloride; Jentaduet (TN) |
(P) unclassified |
| D10265 |
Glipizide and metformin hydrochloride; Metaglip (TN) |
(P) unclassified |
| D10266 |
Glyburide and metformin hydrochloride; Glibenclamide and metformin hydrochloride; Glucovance (TN) |
(P) unclassified |
| D10313 |
Ertugliflozin (USAN/INN) |
(P) unclassified |
| D10317 |
Omarigliptin (JAN/USAN/INN) |
(P) unclassified |
| D10372 |
Palbociclib (JAN/USAN); Ibrance (TN) |
(P) unclassified |
| D10459 |
Empagliflozin (JAN/USAN/INN); Jardiance (TN) |
(P) unclassified |
| D10466 |
Vonoprazan fumarate (JAN/USAN); Takecab (TN); Voquezna (TN) |
(P) Enzyme: CYP2D6 CYP3A4 |
| D10473 |
Insulin peglispro (USAN/INN) |
(P) unclassified |
| D10500 |
Metformin hydrochloride and repaglinide; Prandimet (TN) |
(P) unclassified |
| D10501 |
Fluticasone furoate and vilanterol trifenatate; Breo ellipta (TN); Relvar ellipita (TN) |
(P) Enzyme: CYP3A4 |
| D10502 |
Gemigliptin (INN) |
(P) unclassified |
| D10506 |
Fluticasone propionate and formoterol fumarate hydrate; Flutiform (TN) |
(P) Enzyme: CYP3A4 |
| D10514 |
Dacomitinib (USAN); Dacomitinib hydrate (JAN); Vizimpro (TN) |
(P) CYP inhibition: CYP2D6 |
| D10533 |
Umeclidinium bromide and vilanterol; Anoro (TN) |
(P) Enzyme: CYP2D6 CYP3A4 |
| D10551 |
Ceritinib (JAN/USAN/INN); Zykadia (TN) |
(P) unclassified |
| D10564 |
Amenamevir (JAN/INN); Amenalief (TN) |
(P) unclassified |
| D10566 |
Pasireotide pamoate (JAN); Signifor lar (TN) |
(P) unclassified |
| D10570 |
Insulin degludec (genetical recombination) and insulin aspart (genetical recombination); Ryzodeg (TN) |
(P) unclassified |
| D10586 |
Dapagliflozin and metformin; Xigduo xr (TN) |
(P) unclassified |
| D10587 |
Canagliflozin and metformin; Invokamet (TN) |
(P) unclassified |
| D10588 |
Empagliflozin and linagliptin; Glyxambi (TN) |
(P) unclassified |
| D10643 |
Isavuconazonium sulfate (JAN/USAN); Cresemba (TN) |
(P) unclassified |
| D10669 |
Sotagliflozin (USAN/INN); Inpefa (TN) |
(P) unclassified |
| D10743 |
Vildagliptin and metformin hydrochloride |
(P) unclassified |
| D10752 |
Empagliflozin and metformin; Synjardy (TN) |
(P) unclassified |
| D10762 |
Fosravuconazole L-lysine ethanolate (JAN) |
(P) unclassified |
| D10772 |
Lascufloxacin hydrochloride (JAN); Lasvic (TN) |
(CI,P) unclassified |
| D10774 |
Vonoprazan, amoxicillin and metronidazole; Vonopion (TN) |
(P) Enzyme: CYP2D6 CYP3A4 |
| D10775 |
Vonoprazan, amoxicillin and clarithromycin; Vonosap (TN); Voquenza (TN) |
(P) Enzyme: CYP2D6 CYP3A4 / CYP inhibition: CYP3A4 |
| D10801 |
Letermovir (JAN/USAN/INN); Prevymis (TN) |
(P) unclassified |
| D10826 |
Saxagliptin and dapagliflozin; Qtern (TN) |
(P) unclassified |
| D10865 |
Bexagliflozin (USAN); Brenzavvy (TN) |
(P) unclassified |
| D10897 |
Teneligliptin and canagliflozin; Teneligliptin and canagliflozin; Canalia (TN) |
(P) Enzyme: CYP3A4 |
| D10926 |
Entrectinib (JAN/USAN/INN); Rozlytrek (TN) |
(P) Enzyme: CYP3A4 |
| D10967 |
Ozanimod hydrochloride (JAN/USAN); Zeposia (TN) |
(P) unclassified |
| D10970 |
Pegapamodutide (USAN/INN) |
(P) unclassified |
| D10990 |
Somatrogon (USAN/INN); Somatrogon (genetical recombination) (JAN); Somatrogon-ghla; Ngenla (TN) |
(P) unclassified |
| D10993 |
Tucidinostat (JAN/USAN/INN); Hiyasta (TN) |
(P) unclassified |
| D11012 |
Lorlatinib (JAN/USAN/INN); Lorbrena (TN) |
(P) unclassified |
| D11023 |
Evogliptin (INN) |
(P) unclassified |
| D11027 |
Ropeginterferon alfa-2b (INN); Ropeginterferon alfa-2b (genetical recombination) (JAN); Ropeginterferon alfa-2b-njft; Besremi (TN) |
(P) unclassified |
| D11034 |
Insulin glargine and lixisenatide; Insulin glargine (genetical recombination) and lixisenatide; Soliqua (TN) |
(P) unclassified |
| D11035 |
Fluticasone furoate, umeclidinium bromide and vilanterol; Trelegy ellipta (TN) |
(P) unclassified |
| D11036 |
Glycopyrrolate and formoterol; Bevespi (TN) |
(P) unclassified |
| D11040 |
Apalutamide (JAN/INN); Erleada (TN) |
(P) Enzyme: CYP3A4 / CYP induction: CYP3A4 |
| D11043 |
Ertugliflozin pidolate; Ertugliflozin L-pyroglutamic acid; Steglatro (TN) |
(P) unclassified |
| D11053 |
Encorafenib (JAN/USAN/INN); Braftovi (TN) |
(P) Enzyme: CYP3A4 |
| D11062 |
Osilodrostat phosphate (JAN/USAN); Isturisa (TN) |
(P) Enzyme: CYP2D6 CYP3A4 |
| D11066 |
Ertugliflozin and sitagliptin; Steglujan (TN) |
(P) unclassified |
| D11067 |
Ertugliflozin and metformin; Segluromet (TN) |
(P) unclassified |
| D11072 |
Siponimod fumarate (USAN); Siponimod fumaric acid (JAN); Mayzent (TN) |
(CI) unclassified |
| D11090 |
Ivosidenib (JAN/USAN/INN); Tibsovo (TN) |
(P) unclassified |
| D11138 |
Larotrectinib sulfate (JAN/USAN); Vitrakvi (TN) |
(P) unclassified |
| D11194 |
Somapacitan (USAN/INN); Somapacitan (genetical recombination) (JAN); Somapacitan-beco; Sogroya (TN) |
(P) unclassified |
| D11342 |
Dorzagliatin (USAN) |
(P) unclassified |
| D11360 |
Tirzepatide (JAN/USAN); Mounjaro (TN); Zepbound (TN) |
(P) unclassified |
| D11370 |
Fosnetupitant chloride hydrochloride (JAN/USAN); Arokaris (TN) |
(P) unclassified |
| D11371 |
Capivasertib (JAN/USAN); Truqap (TN) |
(P) Enzyme: CYP3A4 |
| D11422 |
Zanubrutinib (JAN/USAN/INN); Brukinsa (TN) |
(P) unclassified |
| D11454 |
Repotrectinib (JAN/USAN); Augtyro (TN) |
(P) Enzyme: CYP3A4 |
| D11485 |
Tazemetostat hydrobromide (JAN/USAN); Tazverik (TN) |
(P) unclassified |
| D11557 |
Tecovirimat hydrate (JAN); Tecovirimat monohydrate; Tpoxx (TN); Tepoxx (TN) |
(P) unclassified |
| D11567 |
Insulin degludec and liraglutide; Xultophy (TN) |
(P) unclassified |
| D11584 |
Budesonide, glycopyrronium bromide and formoterol fumarate; Budesonide, glycopyrrolate and formoterol fumarate; Breztri (TN) |
(P) unclassified |
| D11603 |
Leriglitazone (USAN/INN); 1-Hydroxypioglitazone |
(P) unclassified |
| D11604 |
Leriglitazone hydrochloride (USAN) |
(P) unclassified |
| D11674 |
Berotralstat hydrochloride (JAN/USAN); Orladeyo (TN) |
(P) CYP inhibition: CYP2D6 CYP3A4 |
| D11708 |
Givosiran sodium (JAN); Givlaari (TN) |
(P) unclassified |
| D11711 |
Dapagliflozin, metformin and saxagliptin; Qternmet xr (TN) |
(P) unclassified |
| D11713 |
Selpercatinib (JAN/USAN/INN); Retevmo (TN) |
(P) Enzyme: CYP3A4 |
| D11804 |
Aspirin and vonoprazan; Cabpirin (TN) |
(P) unclassified |
| D11807 |
Imeglimin hydrochloride (JAN); Twymeeg (TN) |
(P) unclassified |
| D11816 |
Belumosudil mesylate (USAN); Belumosudil mesilate (JAN); Rezurock (TN) |
(P) unclassified |
| D11856 |
Empagliflozin, linagliptin and metformin hydrochloride; Trijardy xr (TN) |
(P) unclassified |
| D11887 |
Daridorexant hydrochloride (JAN/USAN); Quviviq (TN) |
(P) unclassified |
| D11910 |
Danuglipron (USAN) |
(P) unclassified |
| D11911 |
Danuglipron tromethamine (USAN) |
(P) unclassified |
| D11920 |
Pimitespib (JAN); Jeselhy (TN) |
(P) unclassified |
| D11923 |
Lobeglitazone (INN) |
(P) unclassified |
| D11924 |
Beinaglutide (INN) |
(P) unclassified |
| D11968 |
Teneligliptin hydrobromide (JAN) |
(P) Enzyme: CYP3A4 / CYP inhibition: CYP2D6 CYP3A4 |
| D11970 |
Ritlecitinib tosylate (USAN); Ritlecitinib tosilate (JAN); Litfulo (TN) |
(P) unclassified |
| D12050 |
Pirtobrutinib (JAN/USAN); Jaypirca (TN) |
(P) Enzyme: CYP3A4 |
| D12055 |
Sotorasib (JAN/USAN); Lumakras (TN) |
(P) unclassified |
| D12225 |
Mazdutide (USAN) |
(P) unclassified |
| D12245 |
Lazertinib mesylate (USAN); Lazertinib mesilate hydrate (JAN); Lazcluze (TN) |
(P) Enzyme: CYP3A4 |
| D12252 |
Iptacopan hydrochloride (USAN); Iptacopan hydrochloride hydrate (JAN); Iptacopan hydrochloride monohydrate; Fabhalta (TN) |
(P) unclassified |
| D12265 |
Mavacamten (JAN/USAN/INN); Camzyos (TN) |
(P) unclassified |
| D12294 |
Sitagliptin phosphate (JAN) |
(P) unclassified |
| D12341 |
Vurolenatide (USAN/INN) |
(P) unclassified |
| D12358 |
Insulin icodec (USAN/INN); Insulin icodec (genetical recombination) (JAN); Awiqli (TN) |
(P) unclassified |
| D12410 |
Landiolol (USAN/INN) |
(P) unclassified |
| D12484 |
Carfloglitazar (INN) |
(P) unclassified |
| D12529 |
Orforglipron calcium (USAN) |
(P) unclassified |
| D12536 |
Orforglipron (USAN) |
(P) unclassified |
| D12555 |
Lotiglipron (USAN) |
(P) unclassified |
| D12586 |
Mifepristone and misoprostol; Mefeego (TN) |
(P) unclassified |
| D12634 |
Donislecel (USAN); Lantidra (TN) |
(P) unclassified |
| D12703 |
Linagliptin hydrate (JAN); Linagliptin hemihydrate |
(P) unclassified |
| D12735 |
Lotiglipron tromethamine (USAN) |
(P) unclassified |
| D12861 |
Pemvidutide (USAN/INN) |
(P) unclassified |
| D12898 |
Survodutide (USAN/INN) |
(P) unclassified |
| D13015 |
Enavogliflozin (INN) |
(P) unclassified |
| D13028 |
Insulin efsitora alfa (INN); Insulin efsitora alfa (genetical recombination) (JAN) |
(P) unclassified |
| D13055 |
Sitagliptin hydrochloride; Sitagliptin monohydrochloride monohydrate; Brynovin (TN) |
(P) unclassified |
